Determinants of renal disease variability in ADPKD
- PMID: 20219616
- PMCID: PMC2837603
- DOI: 10.1053/j.ackd.2009.12.004
Determinants of renal disease variability in ADPKD
Abstract
In common with other Mendelian diseases, the presentation and progression of autosomal dominant polycystic kidney disease (ADPKD) vary widely in the population. The typical course is of adult-onset disease with ESRD in the 6th decade. However, a small proportion has adequate renal function into the 9th decade, whereas others present with enlarged kidneys as neonates. ADPKD is genetically heterogeneous, and the disease gene is a major determinant of severity; PKD1 on average is associated with ESRD 20 years earlier than PKD2. The majority of PKD1 and PKD2 mutations are likely fully inactivating although recent studies indicate that some alleles retain partial activity (hypomorphic alleles). Homozygotes for such alleles are viable and in combination with an inactivating allele can result in early-onset disease. Hypomorphic alleles and mosaicism may also account for some cases with unusually mild disease. The degree of phenotypic variation detected in families indicates that genetic background influences disease severity. Genome-wide association studies are planned to map common variants associated with severity. Although ADPKD is a simple genetic disease, fully understanding the phenotypic variability requires consideration of influences at the genic, allelic, and genetic background level, and so, ultimately, it is complex.
2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflict of interest or financial disclosures significant to this article.
Figures

Similar articles
-
Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.BMC Nephrol. 2013 Mar 15;14:59. doi: 10.1186/1471-2369-14-59. BMC Nephrol. 2013. PMID: 23496908 Free PMC article.
-
Genotype-phenotype of autosomal dominant polycystic kidney disease in Malta.Eur J Med Genet. 2024 Jun;69:104934. doi: 10.1016/j.ejmg.2024.104934. Epub 2024 Mar 26. Eur J Med Genet. 2024. PMID: 38537868
-
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.J Am Soc Nephrol. 2003 May;14(5):1164-74. doi: 10.1097/01.asn.0000061774.90975.25. J Am Soc Nephrol. 2003. PMID: 12707387
-
Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of PKD1 Hypomorphic Alleles.Genes (Basel). 2023 Jun 7;14(6):1230. doi: 10.3390/genes14061230. Genes (Basel). 2023. PMID: 37372410 Free PMC article. Review.
-
[Genetics and genetic counseling].G Ital Nefrol. 2016 Mar-Apr;33(2):gin/33.2.4. G Ital Nefrol. 2016. PMID: 27067213 Review. Italian.
Cited by
-
Investigation of epigenetics in kidney cell biology.Methods Cell Biol. 2019;153:255-278. doi: 10.1016/bs.mcb.2019.04.015. Epub 2019 Jun 13. Methods Cell Biol. 2019. PMID: 31395383 Free PMC article. Review.
-
PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease.Sci Rep. 2019 Mar 11;9(1):4141. doi: 10.1038/s41598-019-40761-w. Sci Rep. 2019. PMID: 30858458 Free PMC article.
-
Type of PKD1 mutation influences renal outcome in ADPKD.J Am Soc Nephrol. 2013 May;24(6):1006-13. doi: 10.1681/ASN.2012070650. Epub 2013 Feb 21. J Am Soc Nephrol. 2013. PMID: 23431072 Free PMC article.
-
Human Evaluation of the Glu298Asp Polymorphism in NOS3 Gene and its Relationship with Onset age of ESRD in Iranian Patients Suffering from ADPKD.Int J Mol Cell Med. 2012 Spring;1(2):105-12. Int J Mol Cell Med. 2012. PMID: 24551766 Free PMC article.
-
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.J Am Soc Nephrol. 2015 Jan;26(1):160-72. doi: 10.1681/ASN.2013101138. Epub 2014 Jun 5. J Am Soc Nephrol. 2015. PMID: 24904092 Free PMC article.
References
-
- OMIM(TM) Online Mendelian Inheritance in Man. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University; Baltimore, MN: National Center for Biotechnology Information; Bethesda, MD: 2009.
-
- Klahr S, Breyer JA, Beck GJ, et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol. 1995;5:2037–2047. - PubMed
-
- Gabow PA, Johnson AM, Kaehny WD, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;41:1311–1319. - PubMed
-
- Johnson AM, Gabow PA. Identification of pateints with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol. 1997:1560–1567. - PubMed
-
- Grantham JJ, Torres VE, Chapman AB, et al. Volume Progression in Polycystic Kidney Disease. N Engl J Med. 2006;354:2122–2130. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous